Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Human FGF-23 Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 2604FG025
This item is not returnable.
View return policy
Description
The Recombinant Human FGF-23 Protein is derived from NS0. The Recombinant Human FGF-23 Protein has been validated for the following applications: Bioactivity.Specifications
| Lyophilized from a 0.2 μm filtered solution in MOPS, Na 2 SO 4 EDTA and DTT with BSA as a carrier protein. | |
| 26.1 kDa | |
| 25μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 3 months, 2 to 8° C under sterile conditions after reconstitution. | |
| Unconjugated | |
| 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 8074 | |
| FGF-23 | |
| Mouse myeloma cell line,NS0-derived human FGF-23 protein Tyr25-Ile251 (Arg179Gln),with a C-terminal 6-His tag | |
| <0.1 EU per 1μg of the protein by the LAL method. | |
| Recombinant |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title